Be on the Move with PHA in 2019! 

2019 is shaping to be an even more exciting year for PHA with events such as the PHA Forum, many new members and special initiatives, not to mention an extension of our work on Social Determinants of Health! 

The PHA Board thanks its many committed members advancing Population Health for individuals and communities every day.  If you are not a PHA member join the Population Health Alliance today.
Register Now!
PHA Forum 2019: Creating Value through Engagement & Social Determinant Levers
Join PHA for the PHA Forum 2019 from 8 am - Noon on March 18, 2019 in Philadelphia, PA at the Loews Philadelphia hotel. The PHA Forum 2019 will be held in conjunction with the Population Health Colloquium brought to you by the Jefferson College of Population Health. 

The agenda includes the following:

7:30 - 8 am
Networking Breakfast
8:00 - 8:20 am 
Creating Value through Population Health Management Strategies: A Vision for the Future
Speakers: Rose Maljanian, CEO, HealthCAWS; Chairman of the Board, PHA
David Nash, MD, Dean, Jefferson School of Population Health

8:20 - 8:50 am 
Delivering Value through Innovative Population Health Solutions in Medicare Advantage
Speaker: Congresswoman Allyson Y. Schwartz, President & CEO, Better Medicare Alliance

8:50 - 9:20 am 
Innovation Drive to Advance Population Health
Speaker: Gaurav Lal, Executive Director, Innovative Solutions, Merck
9:20 - 9:30 am 
Moderator: Sandeep Wadhwa, MD, MBA, Senior Vice President, Government Programs, Solera Health, Inc.
9:30 - 10:10 am
Social Determinant Levers
Speakers: Mary Jane Osmick, MD, Vice President & Medical Director, American Specialty Health
Brian Ebersole, Senior Director, Springboard Health, Geisinger

10:10 - 10:50 am
Provider Engagement and Community Involvement
Speakers: Jaan Sidorov, MD, Chief Executive Officer, Care Centered Collaborative
Kimberlydawn Wisdom MD, MS, Senior Vice President, Community Health & Equity; Chief Wellness Diversity Officer, Henry Ford; Health System and Michigan’s First Surgeon General

10:50 - 11:40 am
Employer Engaging Low Wage and Aging Workforce
Speaker: Ray Fabius, MD, Co-Founder and President, HealthNEXT
11:40 - 12:00 pm
Closing Remarks
Rose Maljanian, CEO, HealthCAWS; Chairman of the Board, PHA
Sandeep Wadhwa, MD, MBA, Senior Vice President, Government Programs, Solera Health, Inc.

A special thank you to our sponsors:
Silver Sponsors:

Bronze Sponsors:

Register for the PFP Summit 

Register for the PFP Summit, February 25-27 at the Hyatt Regency LAX in Los Angeles, CA. Population Health Alliance will be featured in its presentation, “The Role of Population Health in Value-based Care.” Join speakers Rose Maljanian, Chairman and Chief Executive Officer, HealthCAWS, Inc.; Board Chair, Population Health Alliance, (Moderator); John Haughton MD, MS, Chief Clinical Improvement Officer, Independent Health; Medical Innovation Officer, Chautauqua ACO (AMP); Chief Innovation Officer, Dx-ID; David K. Nace, MD, Chief Medical Officer, Innovaccer; and Ashley Reynolds, PhD, Chief Executive Officer, Kaviva.

PHA Thought Leadership - Don’t Miss This!

Look to our Chairman’s Leadership Circle for the latest thought provoking writings from the industry’s top thought leaders. If you would like to be considered as a contributor please email

ICYMI - PHA Provider Series Webinar: Social Determinants of Health – A Provider Issue?

Mary Jane Osmick, MD
Vice President & Medical Director
American Specialty Health
Quality & Research

The Population Health Alliance (PHA) Quality and Research Committee is tackling the issues of driving value in population health, social determinants, and consumer engagement for its 2018-2019 priorities.   John Robitscher, CEO of the National Association of Chronic Disease Directors will be the guest for the January call. He will be having a dialogue with members about opportunities and strategies for collaborations between population health and public health organizations.

 PHA Q&R is a corporate members only committee. If you are employed at a corporate member company  and are interest in joining please contact Chair Rose Maljanian at
Save the Date!

The PHA Innovation Summit and Capital Caucus 2019 will be held October 29th from 7am - 3pm at Top of the Hill in Washington, D.C. 

Contact to learn more.

NCQA Launches New Population Health Management Programs

As part of its mission to improve the quality of health care, the National Committee for Quality Assurance (NCQA) is launching two new programs. Population Health Program Accreditation assesses how an organization applies population health concepts to programs for a defined population. Population Health Management Prevalidation reviews health IT solutions to determine their ability to support population health management functions. 

Qualifying PHA Members who are accreditation eligible in any category may receive a courtesy copy of the health plan population health accreditation standards to get a glimpse into what is required. Please email with your request.
Population Health Management

Population Health Management is the official journal for the Population Health Alliance. PHA corporate members receive a complimentary subscription. In a previous edition we had a full insert highlighting the PHA Value to Members

In future issues we will include the PHA Member Showcase where your company could be highlighted to the journal's more than 14,000 corporate and individual subscribers.

Please contact Allison King at or 202-737-5476 for more information on being featured in the PHA Member Showcase. 

Population Health Management’s editorial board is seeking manuscript submissions for review. Please review criteria and information for submission

PHA Members in the News
Geisinger Clinical Trial Released after Nearly 1,000 People Participated

A Geisinger clinical trial that followed nearly 1,000 people using a new home test for chronic kidney disease (CKD) shows a high percentage of the participants were happy with the process and preferred it to getting tested in a doctor's office. More

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted a new supplemental Biologics License Application (sBLA) for KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy or in combination with platinum and 5-fluorouracil (5-FU) chemotherapy for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). This sBLA is based in part on data from the pivotal Phase 3 KEYNOTE-048 trial where KEYTRUDA demonstrated a significant improvement in overall survival compared with the standard of care, as monotherapy in patients whose tumors expressed PD-L1 with CPS≥20 and CPS≥1 and in combination with chemotherapy in the total patient population. These data were presented at the European Society for Medical Oncology 2018 Congress. The FDA has granted Priority Review to this sBLA and set a Prescription Drug User Fee Act (PDUFA), or target action, date of June 10, 2019. More

NACCD Promotes Tamika Smith to Director of Membership and Project Management; Staff Continues to Grow in Size and Capability 

National Association of Chronic Disease Directors CEO John W. Robitscher, MPH, announced the addition of several new staff today as well as internal promotions including that of Tamika Smith, MSML, to Director of Membership and Project Management. More

Mercy Newborns Wear Red Knit Hats during American Heart Month

Volunteers for the American Heart Association (AHA) and Mercy are celebrating American Heart Month with knitted-red hats for all babies born at various Mercy hospitals in February. The Little Hats, Big Hearts™ project raises awareness of heart disease, the number one killer of Americans, and congenital heart defects, the most common type of birth defect in the country and the leading killer of infants with birth defects. More

Franciscan Health Cardiac Rehab Team in Indianapolis Earns National Re-Certification

Franciscan Health Indianapolis has been recertified by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). More

BCBSA Releases Study Planned Orthopedic Surgery Spending Increased as Generation X Americans Opt for Knee and Hip Replacements at Earlier Age

Planned knee and hip replacement procedures continue to climb in cost and volume, particularly among younger Americans, according to a review of medical claims data from 2010-2017 by the Blue Cross Blue Shield Association (BCBSA). Knee replacements are up by 17 percent and hip replacements are up 33 percent. Costing more than $25 billion in 2017, planned orthopedic surgeries account for 47 percent of total orthopedic spending, reflecting a 44 percent increase since 2010. During the same time period, the average price of knee and hip procedures increased by 6 percent and 5 percent respectively.  More

BioIQ White Paper Provides Insights for Employers on Tackling High Cost of Flu

The Centers for Disease Control and Prevention (CDC) estimates that flu season will cost U.S. employers more than $31 billion in lost productivity and medical costs. BioIQ today announced the publication of an in-depth white paper, Flu Prevention: The Key to Maintaining a Healthy and Productive Workforce, with background and insights into how to manage the current season, as well as prepare for next year’s inevitable high-impact outbreaks. More

Independent Health’s Health & Wellness Challenge Inspires Thousands to Live Healthier

The Independent Health and Buffalo Bills Health & Wellness Challenge continues to motivate Western New Yorkers to get active, eat right and take charge of their health. More than 27,000 individuals – including 2,725 new participants – registered for this past fall’s Health & Wellness Challenge, which ran from October 22 through December 2. More

Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY™ (romosozumab)

Amgen and UCB (Euronext Brussels: UCB) today announced strong support from the U.S. Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) for the approval of EVENITY™* (romosozumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture after reviewing safety and efficacy data from the pivotal Phase 3 studies. Eighteen of 19 members voted yes for approval. In their discussion, the Committee emphasized the need for post-marketing follow-up. More

American College of Lifestyle Medicine and American College of Preventive Medicine Launch Updated Lifestyle Medicine Education Program

The American College of Lifestyle Medicine and the American College of Preventive Medicine announced the launch of a new and improved Lifestyle Medicine Core Competencies education program that addresses the gaps in health care providers’ knowledge and skills in the treatment of lifestyle-related conditions, the costliest burden in today’s healthcare environment. This one-of-a-kind course prepares clinicians to succeed in value-based reimbursement systems. More

Leavitt Partners Releases “Medicare: Drifting Toward Disaster” White Paper

Leavitt Partners released “Medicare: Drifting Toward Disaster,” a white paper authored by former Utah Governor and U.S. Health and Human Services Secretary Mike Leavitt. The paper discusses how to achieve bipartisan reform in Medicare. With the hospital insurance fund expected to reach insolvency by 2026, the paper sounds the alarm that without Congressional action, the Medicare program threatens to lead to unsustainable health care costs, bitter inter-generational conflict, and widespread loss of coverage. More

Good Measures LLC, Tufts Health Plan, Cambridge Health Alliance, The Greater Boston Food Bank, and the Institute for Community Health Receive Grant from Mass. Attorney General to Distribute Food

Cambridge Health Alliance (CHA), The Greater Boston Food Bank (GBFB), Good Measures LLC, Tufts Health Plan and the Institute for Community Health partnered and are the recipients of a $250,000 grant award from the Office of Massachusetts Attorney General Maura Healey to distribute food to families in need. The award is part of a larger program through the Office of the Attorney General that will fund 13 community-based healthcare partnerships focused on addressing health equity. More
If you would like to have your PHA member company featured in Population Health in the News contact Allison King at (202) 737-5476 
The PHA Board thanks its many committed members advancing Population Health for individuals and communities every day.  If you are not a PHA member join the Population Health Alliance today.
Twitter LinkedIn
powered by emma
Subscribe to our email list.